{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:20:40Z","timestamp":1792012840548,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11259-024-10478-x","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:02:16Z","timestamp":1723611736000},"page":"3177-3186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A pilot study of the proarrhythmic effects of pimobendan injection in clinically healthy cats"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-5259","authenticated-orcid":false,"given":"Mio","family":"Ishizaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-8363","authenticated-orcid":false,"given":"Mizuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1450-1469","authenticated-orcid":false,"given":"Huai-hsun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-0677","authenticated-orcid":false,"given":"Yuichi","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-2701","authenticated-orcid":false,"given":"Naoyuki","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"10478_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jfms.2004.12.003","volume":"7","author":"JA Abbott","year":"2005","unstructured":"Abbott JA (2005) Heart rate and heart rate variability of healthy cats in home and hospital environments. J Feline Med Surg 7:195\u2013202. https:\/\/doi.org\/10.1016\/j.jfms.2004.12.003","journal-title":"J Feline Med Surg"},{"key":"10478_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fphys.2017.00195","volume":"8","author":"J Bai","year":"2017","unstructured":"Bai J, Yin R, Wang K, Zhang H (2017) Mechanisms underlying the emergence of post-acidosis arrhythmia at the tissue level: a theoretical study. Front Physiol 8:195. https:\/\/doi.org\/10.3389\/fphys.2017.00195","journal-title":"Front Physiol"},{"key":"10478_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s1098-612x(02)00133-x","volume":"5","author":"L Ferasin","year":"2003","unstructured":"Ferasin L, Sturgess CP, Cannon MJ, Caney SMA, Gruffydd-Jones TJ, Wotton PR (2003) Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994\u20132001). J Feline Med Surg 5:151\u2013159. https:\/\/doi.org\/10.1016\/s1098-612x(02)00133-x","journal-title":"J Feline Med Surg"},{"key":"10478_CR4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.amjcard.2006.07.043","volume":"98","author":"P Flevari","year":"2006","unstructured":"Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Th Kremastinos D (2006) Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischaemic or dilated cardiomyopathy. Am J Cardiol 98:1641\u20131645. https:\/\/doi.org\/10.1016\/j.amjcard.2006.07.043","journal-title":"Am J Cardiol"},{"key":"10478_CR5","doi-asserted-by":"publisher","unstructured":"Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C (2002) A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med 16:255\u2013261. https:\/\/doi.org\/10.1892\/0891-6640(2002)016%3C0255:adrpso%3E2.3.co;2","DOI":"10.1892\/0891-6640(2002)016%3C0255:adrpso%3E2.3.co;2"},{"key":"10478_CR6","doi-asserted-by":"publisher","unstructured":"Fuentes VL, Abbott J, Chetboul V, C\u00f4t\u00e9 E, Fox PR, H\u00e4ggstr\u00f6m J, Kittleson MD, Schober K, Stern JA (2020) ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. J Vet Intern Med 34:1062\u20131077. https:\/\/doi.org\/10.1111\/jvim.15745","DOI":"10.1111\/jvim.15745"},{"key":"10478_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jvc.2021.03.005","volume":"35","author":"Y Fujii","year":"2021","unstructured":"Fujii Y, Sugimoto K, Omichi M, Kanai K, Orito K (2021) A pilot study investigating the effect of pimobendan on the cardiac rhythm and selected echocardiographic parameters of healthy cats. J Vet Cardiol 35:74\u201383. https:\/\/doi.org\/10.1016\/j.jvc.2021.03.005","journal-title":"J Vet Cardiol"},{"key":"10478_CR8","first-page":"159","volume":"300","author":"Y Furukawa","year":"1989","unstructured":"Furukawa Y, Akahane K, Ogiwara Y, Haniuda M, Chiba S (1989) Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations. Arch Int Pharmacodyn Ther 300:159\u2013173","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10478_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2460\/javma.241.1.89","volume":"241","author":"SG Gordon","year":"2012","unstructured":"Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW (2012) Effect of oral administration of pimobendan in cats with heart failure. J Am Vet Med Assoc 241:89\u201394. https:\/\/doi.org\/10.2460\/javma.241.1.89","journal-title":"J Am Vet Med Assoc"},{"key":"10478_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/a:1007832921391","volume":"14","author":"K Gy\u00f6rgy","year":"2000","unstructured":"Gy\u00f6rgy K, V\u00e9gh A, Rastegar MA, Papp JG, Parratt JR (2000) Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning. Cardiovasc Drugs Ther 14:481\u2013488. https:\/\/doi.org\/10.1023\/a:1007832921391","journal-title":"Cardiovasc Drugs Ther"},{"key":"10478_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jvc.2012.06.002","volume":"14","author":"AS Hanzlicek","year":"2012","unstructured":"Hanzlicek AS, Gehring R, Kukanich B, Kukanich KS, Borgarelli M, Smee N, Olson EE, Margiocco M (2012) Pharmacokinetics of oral pimobendan in healthy cats. J Vet Cardiol 14:489\u2013496. https:\/\/doi.org\/10.1016\/j.jvc.2012.06.002","journal-title":"J Vet Cardiol"},{"key":"10478_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.echo.2004.04.037","volume":"17","author":"K Harada","year":"2004","unstructured":"Harada K, Toyono M, Yamamoto F (2004) Assessment of right ventricular function during exercise with quantitative doppler tissue imaging in children late after repair of tetralogy of Fallot. J Am Soc Echocardiogr 17:863\u2013869. https:\/\/doi.org\/10.1016\/j.echo.2004.04.037","journal-title":"J Am Soc Echocardiogr"},{"key":"10478_CR13","first-page":"275","volume-title":"Levick\u2019s introduction to cardiovascular physiology","author":"N Herring","year":"2018","unstructured":"Herring N, Paterson DJ (2018a) Coronary circulation. Levick\u2019s introduction to cardiovascular physiology, 6th edn. CRC, Boca Raton, pp 275\u2013281","edition":"6"},{"key":"10478_CR14","first-page":"58","volume-title":"Levick\u2019s introduction to cardiovascular physiology","author":"N Herring","year":"2018","unstructured":"Herring N, Paterson DJ (2018b) Effect of sympathetic stimulation. Levick\u2019s introduction to cardiovascular physiology, 6th edn. CRC, Boca Raton, pp 58\u201359","edition":"6"},{"key":"10478_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1292\/jvms.18-0185","volume":"81","author":"Y Hori","year":"2019","unstructured":"Hori Y, Taira H, Nakajima Y, Ishikawa Y, Yumoto Y, Maekawa Y, Oshiro A (2019) Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs. J Vet Med Sci 81:22\u201325. https:\/\/doi.org\/10.1292\/jvms.18-0185","journal-title":"J Vet Med Sci"},{"key":"10478_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.yjmcc.2010.01.011","volume":"48","author":"S Huke","year":"2010","unstructured":"Huke S, Knollmann BC (2010) Increased myofilament Ca2+ sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol 48:824\u2013833. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.01.011","journal-title":"J Mol Cell Cardiol"},{"key":"10478_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/bf02058309","volume":"3","author":"J Imagawa","year":"1987","unstructured":"Imagawa J, Satoh K, Taira N (1987) Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations. Heart Vessels 3:182\u2013189. https:\/\/doi.org\/10.1007\/bf02058309","journal-title":"Heart Vessels"},{"key":"10478_CR19","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/jvim.16537","volume":"36","author":"JL Kaplan","year":"2022","unstructured":"Kaplan JL, Visser LC, Gunther-Harrington CT, Ontiveros ES, Wittenburg LA, Palm CA, Stern JA (2022) Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease. J Vet Intern Med 36:1892\u20131899. https:\/\/doi.org\/10.1111\/jvim.16537","journal-title":"J Vet Intern Med"},{"key":"10478_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"Keene BW, Atkins CE, Bonagura JD, Fox PR, H\u00e4ggstr\u00f6m J, Fuentes VL, Oyama MA, Rush JE, Stepien R, Uechi M (2019) ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 33:1127\u20131140. https:\/\/doi.org\/10.1111\/jvim.15488","journal-title":"J Vet Intern Med"},{"key":"10478_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1892\/0891-6640(2006)20[65:ptdiin]2.0.co;2","volume":"20","author":"H Koffas","year":"2006","unstructured":"Koffas H, Dukes-McEwan J, Corcoran BM, Moran CM, French A, Sboros V, Simpson K, McDicken WN (2006) Pulsed tissue doppler imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 20:65\u201377. https:\/\/doi.org\/10.1892\/0891-6640(2006)20[65:ptdiin]2.0.co;2","journal-title":"J Vet Intern Med"},{"key":"10478_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jvc.2011.08.001","volume":"13","author":"JM Macgregor","year":"2011","unstructured":"Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL (2011) Use of pimobendan in 170 cats (2006\u20132010). J Vet Cardiol 13:251\u2013260. https:\/\/doi.org\/10.1016\/j.jvc.2011.08.001","journal-title":"J Vet Cardiol"},{"key":"10478_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00002512-199812030-00003","volume":"12","author":"L Mathew","year":"1998","unstructured":"Mathew L, Katz SD (1998) Calcium sensitising agents in heart failure. Drugs Aging 12:191\u2013204. https:\/\/doi.org\/10.2165\/00002512-199812030-00003","journal-title":"Drugs Aging"},{"key":"10478_CR24","doi-asserted-by":"publisher","unstructured":"Midkiff AM, Chew DJ, Randolph JF, Center SA, DiBartola SP (2000) Idiopathic hypercalcemia in cats. J Vet Intern Med 14:619\u2013626. https:\/\/doi.org\/10.1892\/0891-6640(2000)014%3C0619:ihic%3E2.3.co;2","DOI":"10.1892\/0891-6640(2000)014%3C0619:ihic%3E2.3.co;2"},{"key":"10478_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1939-1676.2008.0116.x","volume":"22","author":"MR O\u2019Grady","year":"2008","unstructured":"O\u2019Grady MR, Minors SL, O\u2019Sullivan ML, Horne R (2008) Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med 22:897\u2013904. https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0116.x","journal-title":"J Vet Intern Med"},{"key":"10478_CR26","doi-asserted-by":"publisher","unstructured":"Ogawa M, Kaba SF, Miyakawa H, Hsu H, Miyagawa Y, Takemura N (2022a) A pilot study of patch Holter electrocardiograph recordings in healthy cats. Open Vet J 12:489\u2013494. https:\/\/doi.org\/10.5455\/ovj.2022.v12.i4.10","DOI":"10.5455\/ovj.2022.v12.i4.10"},{"key":"10478_CR27","doi-asserted-by":"publisher","unstructured":"Ogawa M, Kawamura A, Akabane R, Sakatani A, Miyakawa H, Hsu HH, Miyagawa Y, Takemura N (2022b) Effects of ivabradine and atenolol on heart rate and heart rate variability in healthy cats over a 24\u00a0h period: a pilot study. Vet Rec Open 9:e28. https:\/\/doi.org\/10.1002\/vro2.28","DOI":"10.1002\/vro2.28"},{"key":"10478_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fvets.2019.00015","volume":"6","author":"MS Oldach","year":"2019","unstructured":"Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Harris SP, Stern JA (2019) Cardiac effects of a single dose of pimobendan in cats with hypertrophic cardiomyopathy; a randomized, placebo-controlled, crossover study. Front Vet Sci 6:15. https:\/\/doi.org\/10.3389\/fvets.2019.00015","journal-title":"Front Vet Sci"},{"key":"10478_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12917-021-02799-9","volume":"17","author":"MS Oldach","year":"2021","unstructured":"Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Visser LC, Stern JA (2021) Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy. BMC Vet Res 17:89. https:\/\/doi.org\/10.1186\/s12917-021-02799-9","journal-title":"BMC Vet Res"},{"key":"10478_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","volume":"119","author":"PS Pagel","year":"1996","unstructured":"Pagel PS, Hettrick DA, Warltier DC (1996) Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 119:609\u2013615. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15716.x","journal-title":"Br J Pharmacol"},{"key":"10478_CR31","first-page":"859","volume-title":"Plumb\u2019s veterinary drug handbook","author":"DC Plumb","year":"2019","unstructured":"Plumb DC (2019) Pimobendan. Plumb\u2019s veterinary drug handbook, 9th edn. Wiley-Blackwell, Hoboken, p 859","edition":"9"},{"key":"10478_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/circresaha.107.158774","volume":"101","author":"L Pohlmann","year":"2007","unstructured":"Pohlmann L, Kr\u00f6er I, Vignier N, Schlossarek S, Kr\u00e4mer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101:928\u2013938. https:\/\/doi.org\/10.1161\/circresaha.107.158774","journal-title":"Circ Res"},{"key":"10478_CR33","doi-asserted-by":"publisher","unstructured":"Prieto-Ramos J, McNaught K, French AT (2016a) Use of intravenous pimobendan in cats with heart failure. Oral research abstract presented at the 25th ECVIM-CA Congress. J Vet Intern Med 30:348\u2013439. https:\/\/doi.org\/10.1111\/2Fjvim.13647","DOI":"10.1111\/2Fjvim.13647"},{"key":"10478_CR34","doi-asserted-by":"publisher","first-page":"e000273","DOI":"10.1136\/vetreccr-2015-000273","volume":"4","author":"J Prieto-Ramos","year":"2016","unstructured":"Prieto-Ramos J, McNaught K, French AT (2016b) The novel use of intravenous pimobendane and oral torasemide in a cat with congestive heart failure secondary to end-stage hypertrophic cardiomyopathy. Vet Rec Case Rep 4:e000273. https:\/\/doi.org\/10.1136\/vetreccr-2015-000273","journal-title":"Vet Rec Case Rep"},{"key":"10478_CR35","doi-asserted-by":"crossref","unstructured":"Riggins J, Douglas T, deSouza IS (2021) Ventricular tachycardia as a consequence of triggered activity. Am J Emerg Med 44:480.e5\u2013480.e7","DOI":"10.1016\/j.ajem.2020.11.008"},{"key":"10478_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/jvim.16054","volume":"35","author":"KE Schober","year":"2021","unstructured":"Schober KE, Rush JE, Fuentes VL, Glaus T, Summerfield NJ, Wright K, Lehmkuhl L, Wess G, Sayer MP, Loureiro J, MacGregor J, Mohren N (2021) Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: results of a prospective, double-blind, randomized, nonpivotal, exploratory field study. J Vet Intern Med 35:789\u2013800. https:\/\/doi.org\/10.1111\/jvim.16054","journal-title":"J Vet Intern Med"},{"key":"10478_CR37","doi-asserted-by":"publisher","unstructured":"Sugimoto K, Sugita K, Orito K, Fujii Y (2022) Repeated-dose pharmacodynamics of pimobendan in healthy cats. Anim (Basel) 12:981. https:\/\/doi.org\/10.3390\/ani12080981","DOI":"10.3390\/ani12080981"},{"key":"10478_CR38","doi-asserted-by":"publisher","first-page":"771244","DOI":"10.3389\/fvets.2021.771244","volume":"8","author":"R Suzuki","year":"2021","unstructured":"Suzuki R, Saito T, Yuchi Y, Kanno H, Teshima T, Matsumoto H, Koyama H (2021) Detection of congestive heart failure and myocardial dysfunction in cats with cardiomyopathy by using two-dimensional speckle-tracking echocardiography. Front Vet Sci 8:771244. https:\/\/doi.org\/10.3389\/fvets.2021.771244","journal-title":"Front Vet Sci"},{"key":"10478_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0033-0620(05)80005-2","volume":"38","author":"JE Tisdale","year":"1995","unstructured":"Tisdale JE, Patel R, Webb CR, Borzak S, Zarowitz BJ (1995) Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog Cardiovasc Dis 38:167\u2013180. https:\/\/doi.org\/10.1016\/s0033-0620(05)80005-2","journal-title":"Prog Cardiovasc Dis"},{"key":"10478_CR40","doi-asserted-by":"crossref","unstructured":"van Meel JC, Diederen W (1989) Hemodynamic profile of the cardiotonic agent pimobendan. J Cardiovasc Pharmacol\u00a014 Suppl 2:S1\u2013S6","DOI":"10.1097\/00005344-198906142-00002"},{"key":"10478_CR41","doi-asserted-by":"publisher","unstructured":"Vatner SF, Higgins CB, Franklin D, Braunwald E (1972) Role of tachycardia in mediating the coronary hemodynamic response to severe exercise. J Appl Physiol 32:380\u2013385. https:\/\/doi.org\/10.1152\/jappl.1972.32.3.380","DOI":"10.1152\/jappl.1972.32.3.380"},{"issue":"1\u20132","key":"10478_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0014-2999(86)90733-8","volume":"126","author":"PD Verdouw","year":"1986","unstructured":"Verdouw PD, Hartog JM, Duncker DJ (1986) Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol 126(1\u20132):21\u201330. https:\/\/doi.org\/10.1016\/0014-2999(86)90733-8","journal-title":"Eur J Pharmacol"},{"key":"10478_CR43","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/jvim.15920","volume":"34","author":"JL Ward","year":"2020","unstructured":"Ward JL, Kussin EZ, Tropf MA, Tou SP, DeFrancesco TC, Keene BW (2020) Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy. J Vet Intern Med 34:2211\u20132222. https:\/\/doi.org\/10.1111\/jvim.15920","journal-title":"J Vet Intern Med"},{"key":"10478_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jvc.2016.07.001","volume":"18","author":"M Yata","year":"2016","unstructured":"Yata M, McLachlan AJ, Foster DJ, Hanzlicek AS, Beijerink NJ (2016) Single-dose pharmacokinetics and cardiovascular effects of oral pimobendan in healthy cats. J Vet Cardiol 18:310\u2013325. https:\/\/doi.org\/10.1016\/j.jvc.2016.07.001","journal-title":"J Vet Cardiol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-024-10478-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T16:32:22Z","timestamp":1727713942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-024-10478-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10478"],"URL":"https:\/\/doi.org\/10.1007\/s11259-024-10478-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3723494\/v1","asserted-by":"object"}]},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Nippon Veterinary and Life Science University Experimental Animal Committee (No. 2022-S32).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}